WELL Health Technologies Corp. (WELL.TO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+8.7%

CA$4.53

vs CA$4.17 price

Levered DCF

CA$4.18

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

1.14

Distress zone

Rating

B-

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-133×	52.77×	12,833.33×	32.87×	-30.69×	-410.71×	-19.4×	-14.66×
P/B	7.73×	1.95×	1.19×	0.86×	1.52×	4.96×	4.73×	2.95×
P/S	4.77×	1.84×	1.17×	1.1×	3.1×	21.46×	4.61×	5.07×
EV / EBITDA	35.08×	16.21×	12.7×	9.85×	60.06×	-1,587.89×	-37.22×	-13.75×
Gross margin	37.5%	39.5%	48.0%	53.3%	50.8%	42.2%	33.5%	29.3%
Operating margin	8.1%	-3.3%	4.5%	4.1%	-2.1%	-19.7%	-17.1%	-34.2%
Net margin	-3.6%	3.5%	0.0%	3.4%	-10.2%	-5.2%	-23.8%	-34.7%
Current ratio	1.03×	0.91×	1.15×	1.11×	1.04×	4.57×	2.25×	1.71×
Debt / equity	0.82×	0.49×	0.56×	0.49×	0.65×	0.11×	0.6×	0×
Interest coverage	2.07×	-0.82×	1.09×	1.02×	-0.79×	-5.53×	-3.88×	-104.42×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-5.8%	3.8%	0.0%	2.6%	-5.0%	-1.2%	-24.4%	-20.1%
Return on invested capital	5.1%	-2.1%	2.3%	1.9%	-0.5%	-1.5%	-10.9%	-19.0%
Return on assets	-2.4%	1.8%	0.0%	1.4%	-2.4%	-1.0%	-13.3%	-16.0%
Free cash flow yield	1.3%	-0.4%	4.1%	11.2%	2.1%	-0.6%	-2.1%	-4.3%
Earnings yield	-0.8%	1.9%	0.0%	3.0%	-3.3%	-0.2%	-5.2%	-6.8%
Enterprise value	CA$7.3B	CA$2B	CA$1.3B	CA$936.3M	CA$1.3B	CA$1B	CA$154.7M	CA$27.4M
Net debt / EBITDA	2.79×	2.39×	3.76×	3.26×	15.99×	99.1×	-0.85×	1.25×
Cash conversion cycle (days)	16	25	10	-6	-6	2	-22	-73